Profiel
Irackly Mtibelishvily worked as a Director at Argos Therapeutics, Inc. from 2016 to 2018.
He graduated from Moscow State Institute of International Relations and the University of Virginia School of Law with graduate degrees.
Eerdere bekende functies van Irackly Mtibelishvily
| Bedrijven | Functie | Einde |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Directeur/Bestuurslid | 30-11-2018 |
Opleiding van Irackly Mtibelishvily
| University of Virginia School of Law | Graduate Degree |
| Moscow State Institute of International Relations | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
